advertisement
Abstract #25882 Published in IGR 12-2
Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients
Moss AM; Harris A; Siesky B; Rusia D; Williamson KM; Shoshani YClinical Ophthalmology 2010; 4: 233-241
Topical hypotensive therapy with both timolol and carbonic anhydrase inhibitors has been shown to be efficacious at reducing intraocular pressure. Many prospective studies have also suggested that carbonic anhydrase inhibitors augment ocular blood flow and vascular regulation independent of their hypotensive effects. Although consistent in their findings, these studies must be cautiously interpreted due to the limitations of study design and specific blood flow imaging modalities. The purpose of this review is to appraise and critically evaluate the current body of literature investigating the effects of combined treatment with topical carbonic anhydrase inhibitors and timolol in patients with glaucoma with respect to ocular blood flow, visual function, and optic nerve head structure.
A. Harris. Cellular and Integrative Physiology, Indiana University School of Medicine, 702 Rotary Circle, Indianapolis, IN 46202, United States. alharris@indiana.edu
Classification:
6.11 Bloodflow measurements (Part of: 6 Clinical examination methods)
11.13.2 Betablocker and carbon anhydrase inhibitor (Part of: 11 Medical treatment > 11.13 Combination therapy)
